Log in

NASDAQ:BLFS - BioLife Solutions Stock Price, Forecast & News

-0.58 (-3.58 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $15.63
50-Day Range
MA: $15.29
52-Week Range
Now: $15.63
Volume141,954 shs
Average Volume160,590 shs
Market Capitalization$319.63 million
P/E Ratio33.98
Dividend YieldN/A
BioLife Solutions, Inc develops, manufactures, and markets grade cell and tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced cell damage and death. The company offers CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing; and HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:BLFS



Sales & Book Value

Annual Sales$19.74 million
Cash Flow$0.16 per share
Book Value$2.33 per share


Net Income$3.27 million


Market Cap$319.63 million
Next Earnings Date3/11/2020 (Confirmed)
OptionableNot Optionable

Receive BLFS News and Ratings via Email

Sign-up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

BioLife Solutions (NASDAQ:BLFS) Frequently Asked Questions

What is BioLife Solutions' stock symbol?

BioLife Solutions trades on the NASDAQ under the ticker symbol "BLFS."

How were BioLife Solutions' earnings last quarter?

BioLife Solutions Inc (NASDAQ:BLFS) announced its quarterly earnings data on Thursday, August, 9th. The medical equipment provider reported $0.05 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.04 by $0.01. The medical equipment provider had revenue of $5.18 million for the quarter, compared to the consensus estimate of $5.20 million. BioLife Solutions had a net margin of 46.77% and a return on equity of 5.37%. View BioLife Solutions' Earnings History.

When is BioLife Solutions' next earnings date?

BioLife Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for BioLife Solutions.

How can I listen to BioLife Solutions' earnings call?

BioLife Solutions will be holding an earnings conference call on Wednesday, March 11th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has BioLife Solutions issued on next quarter's earnings?

BioLife Solutions updated its FY 2020 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$50-56 million, compared to the consensus revenue estimate of $$42.95 million.

What price target have analysts set for BLFS?

7 analysts have issued 12 month price objectives for BioLife Solutions' shares. Their forecasts range from $22.00 to $27.00. On average, they anticipate BioLife Solutions' stock price to reach $24.29 in the next year. This suggests a possible upside of 55.4% from the stock's current price. View Analyst Price Targets for BioLife Solutions.

What is the consensus analysts' recommendation for BioLife Solutions?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioLife Solutions in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioLife Solutions.

Has BioLife Solutions been receiving favorable news coverage?

News stories about BLFS stock have been trending very negative recently, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. BioLife Solutions earned a media sentiment score of -3.5 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for BioLife Solutions.

Who are some of BioLife Solutions' key competitors?

What other stocks do shareholders of BioLife Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioLife Solutions investors own include Canopy Growth (CGC), AbbVie (ABBV), Micron Technology (MU), NVIDIA (NVDA), Square (SQ), Twilio (TWLO), Amarin (AMRN), Cara Therapeutics (CARA), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

Who are BioLife Solutions' key executives?

BioLife Solutions' management team includes the folowing people:
  • Mr. Michael P. Rice, Pres, CEO & Director (Age 56)
  • Mr. Roderick de Greef, CFO & Sec. (Age 59)
  • Dr. Aby J. Mathew, Chairman of Scientific Advisory Board, Chief Technology Officer and Sr. VP (Age 47)
  • Ms. Karen Foster, VP of Operations (Age 59)
  • Mr. Kevin O'Donnell, VP of Cold Chain Standards, Practices & Compliance

Who are BioLife Solutions' major shareholders?

BioLife Solutions' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Casdin Capital LLC (12.07%), Russell Investments Group Ltd. (2.72%), Driehaus Capital Management LLC (2.33%), Royce & Associates LP (1.08%), Essex Investment Management Co. LLC (1.04%) and Parkman Healthcare Partners LLC (0.81%). Company insiders that own BioLife Solutions stock include Andrew G Hinson, Casdin Partners Master Fund, L, Greef Roderick De, James Mathers, Johan Wedell-Wedellsborg, Joseph C Schick, Michael Rice, Raymond W Cohen, Thomas Girschweiler, Todd Berard and Walter Villiger. View Institutional Ownership Trends for BioLife Solutions.

Which institutional investors are selling BioLife Solutions stock?

BLFS stock was sold by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Cadence Capital Management LLC, Schonfeld Strategic Advisors LLC, Perkins Capital Management Inc., Russell Investments Group Ltd., Driehaus Capital Management LLC, Bank of America Corp DE and Penbrook Management LLC. Company insiders that have sold BioLife Solutions company stock in the last year include Andrew G Hinson, Greef Roderick De, James Mathers, Johan Wedell-Wedellsborg, Joseph C Schick, Michael Rice, Raymond W Cohen, Todd Berard and Walter Villiger. View Insider Buying and Selling for BioLife Solutions.

Which institutional investors are buying BioLife Solutions stock?

BLFS stock was bought by a variety of institutional investors in the last quarter, including Parkman Healthcare Partners LLC, Roubaix Capital LLC, Marshall Wace LLP, Bank of Montreal Can, Casdin Capital LLC, Isthmus Partners LLC, Goldman Sachs Group Inc. and Franklin Resources Inc.. View Insider Buying and Selling for BioLife Solutions.

How do I buy shares of BioLife Solutions?

Shares of BLFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BioLife Solutions' stock price today?

One share of BLFS stock can currently be purchased for approximately $15.63.

How big of a company is BioLife Solutions?

BioLife Solutions has a market capitalization of $319.63 million and generates $19.74 million in revenue each year. The medical equipment provider earns $3.27 million in net income (profit) each year or $0.14 on an earnings per share basis. BioLife Solutions employs 54 workers across the globe.View Additional Information About BioLife Solutions.

What is BioLife Solutions' official website?

The official website for BioLife Solutions is http://www.biolifesolutions.com/.

How can I contact BioLife Solutions?

BioLife Solutions' mailing address is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. The medical equipment provider can be reached via phone at 425-402-1400 or via email at [email protected]

MarketBeat Community Rating for BioLife Solutions (NASDAQ BLFS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  244 (Vote Outperform)
Underperform Votes:  204 (Vote Underperform)
Total Votes:  448
MarketBeat's community ratings are surveys of what our community members think about BioLife Solutions and other stocks. Vote "Outperform" if you believe BLFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BLFS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Correction

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel